<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
  xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://researchpepnews.com/articles/overseas-peptide-supply-chain-quality-traceability</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31</news:publication_date>
      <news:title>From an Overseas Factory to a Research Vial: The Missing Links in Peptide Quality</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/peptide-receiving-chain-of-custody-3ml.png</image:loc>
      <image:caption>A laboratory scientist checks a bulk peptide container against receiving records before material moves into three short 3 mL serum vials. Every handoff needs a batch identity and a documented chain of custody. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/bpc157-blood-pressure-research</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31</news:publication_date>
      <news:title>BPC-157 and Blood Pressure: What the Research Actually Tells Us</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/bpc157-blood-pressure-evidence-review.png</image:loc>
      <image:caption>A clinician measures a seated adult’s blood pressure with an upper-arm cuff in an exam room. Published BPC-157 research does not establish how the peptide affects blood pressure in people. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/glp1-rapid-weight-loss-lean-mass-muscle-protection</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30</news:publication_date>
      <news:title>Rapid Weight Loss Can Cost Muscle: How Researchers Are Studying Lean-Mass Protection</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/glp1-lean-mass-strength-assessment.png</image:loc>
      <image:caption>An older adult completes a supervised sit-to-stand strength assessment in a clinical exercise room. Researchers increasingly evaluate strength and physical function alongside body weight when studying lean-mass preservation. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/glp1-slow-responders-first-weeks-weight-loss</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30</news:publication_date>
      <news:title>Why Am I Not Losing Weight Yet? What GLP-1 Trials Say About Slow Responders</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/glp1-slow-response-clinic-review.png</image:loc>
      <image:caption>A clinician and patient review a gradual weight trend during an obesity-medicine follow-up. Early response to GLP-1-based treatment is evaluated over time while introductory doses are used to build tolerability. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
</urlset>